Earnings Per Share, Diluted of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: GBP/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
TC BioPharm (Holdings) plc annual and quarterly Earnings Per Share, Diluted in GBP/shares history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Earnings Per Share, Diluted for the quarter ending 31 Mar 2024 was -0.11, a 65% increase year-over-year.
  • TC BioPharm (Holdings) plc annual Earnings Per Share, Diluted for 2024 was -0.03, a 97% increase from 2023.
  • TC BioPharm (Holdings) plc annual Earnings Per Share, Diluted for 2023 was -0.96, a 50% increase from 2022.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Annual (GBP/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)
Earnings Per Share, Diluted, Quarterly (GBP/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Annual Earnings Per Share, Diluted (GBP/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -0.03 +0.93 +97% 01 Jan 2024 31 Dec 2024 20-F 09 May 2025 2024 FY
2023 -0.96 +0.95 +50% 01 Jan 2023 31 Dec 2023 20-F 09 May 2025 2024 FY
2022 -1.91 01 Jan 2022 31 Dec 2022 20-F 09 May 2025 2024 FY

TC BioPharm (Holdings) plc Quarterly Earnings Per Share, Diluted (GBP/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 -0.11 +0.2 +65% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 -0.31 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.